|
|
|
|
|||||
|
|
|
New: Introducing “Why Is It Moving?” - lightning-fast, AI-driven explanations of stock moves
Medtronic plc (NYSE:MDT) is included among the Top 15 Growth Stocks for Long-Term Investors.
Medtronic plc (NYSE:MDT) stands as the world’s largest producer of biomedical devices and implantable technologies. The company operates through four main segments: Cardiovascular, Neuroscience, Medical Surgical, and Diabetes.
Medtronic plc (NYSE:MDT) continues to pursue growth through both internal innovation and strategic acquisitions. Its strong focus on research and development fuels organic expansion, while targeted acquisitions further strengthen its portfolio. The company also sees significant growth potential in emerging markets, with an established presence in regions such as China, India, and Africa, markets characterized by large populations and rapidly expanding economies.
Revenue from these emerging markets has been growing at a double-digit pace for several years, outpacing the growth rate in the United States, which currently contributes just over half of Medtronic plc (NYSE:MDT)’s total revenue. In fact, in fiscal Q2 2025, the company recorded revenue of $4.2 billion from its US operations, while international markets contributed $4.3 billion.
Since 2021, Medtronic plc (NYSE:MDT) has completed nine smaller, tuck-in acquisitions worth more than $3.3 billion, reflecting its commitment to expanding its capabilities and product offerings. The company’s key competitive strength lies in its robust research and development program, with annual R&D spending consistently exceeding $2 billion. This investment has been central to its ability to deliver continuous product innovation and maintain its leadership in the medical technology space.
Moreover, Medtronic plc (NYSE:MDT)’s dividend growth continues to draw investor interest. The company has increased its dividend for 48 consecutive years, underscoring its financial stability and shareholder-focused approach. Currently, it offers a quarterly dividend of $0.71 per share and has a dividend yield of 2.98%, as of October 12.
While we acknowledge the potential of MDT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 12 Most Promising Dividend Stocks According to Wall Street Analysts and 14 Best Food Dividend Stocks To Buy According to Analysts.
Disclosure: None.
| 3 hours | |
| 14 hours | |
| Oct-09 | |
| Oct-09 | |
| Oct-08 | |
| Oct-04 | |
| Oct-03 | |
| Oct-03 | |
| Oct-02 | |
| Oct-02 | |
| Oct-02 | |
| Oct-01 | |
| Sep-29 | |
| Sep-29 | |
| Sep-29 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite